Cranial Electrotherapy Stimulation
What is CES?
Cranial Electrotherapy Stimulation (CES) is a non-invasive neuromodulation therapy that delivers low-level electrical currents to the scalp to influence neurotransmitter activity in the brain, helping to alleviate symptoms of anxiety, depression, and insomnia. CES treatment is administered using a small, portable device. Patients typically attach electrodes to the earlobes, scalp, or forehead, with the current set at microampere (µA) levels and a frequency ranging from approximately 0.5 to 4 Hz. Due to the extremely low current, patients usually feel only a mild tingling sensation or nothing at all.
CES has been approved by the U.S. FDA as a medical treatment for over 35 years, and in recent years, it has also been approved by Taiwan's TFDA as a medical device. Supported by numerous clinical trials across different countries, CES devices were reclassified by the U.S. FDA in December 2019 as Class II medical devices—placing them under the same safety regulations as blood pressure monitors. CES is recognized by the FDA as a safe and effective treatment for insomnia, anxiety, and depression, and may be used as an alternative to or in conjunction with medication.
Who Is a Good Candidate for CES?
- Individuals with anxiety symptoms: People who frequently feel nervous, worried, or excessively anxious
- Individuals with depressive symptoms: People who consistently experience low mood, lack of interest, or low motivation
- Individuals with sleep disturbances: People who have difficulty falling asleep, wake up frequently during the night, or suffer from poor sleep quality
Before starting CES treatment, it is recommended to consult a medical professional for an evaluation to ensure the therapy is suitable for your condition.
Please note that CES is not recommended for individuals with pacemakers or for those who are pregnant.